Karan Kanhai

603 total citations
16 papers, 232 citations indexed

About

Karan Kanhai is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Karan Kanhai has authored 16 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Karan Kanhai's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Karan Kanhai is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Karan Kanhai collaborates with scholars based in United States, Netherlands and United Kingdom. Karan Kanhai's co-authors include Sung Ryul Shim, Young Myoung Ko, Jae Heon Kim, J.A. Avontuur, S. L. C. E. Buijk, Frits van Rhee, David C. Fajgenbaum, Hajo A. Bruining, Corey Casper and Razelle Kurzrock and has published in prestigious journals such as Blood, CHEST Journal and Critical Care Medicine.

In The Last Decade

Karan Kanhai

15 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karan Kanhai United States 8 85 72 63 53 46 16 232
Ali Yıldız Türkiye 8 67 0.8× 34 0.5× 23 0.4× 18 0.3× 13 0.3× 46 386
Jiyan Yuan China 9 33 0.4× 61 0.8× 64 1.0× 15 0.3× 27 0.6× 13 340
Takamasa Kobayashi Japan 10 63 0.7× 13 0.2× 21 0.3× 51 1.0× 110 2.4× 41 333
Jae Duck Choi South Korea 12 258 3.0× 115 1.6× 62 1.0× 21 0.4× 7 0.2× 36 385
Mithat Büyükçelik Türkiye 11 73 0.9× 38 0.5× 22 0.3× 6 0.1× 13 0.3× 28 364
Kiyohide Sakai Japan 11 104 1.2× 116 1.6× 17 0.3× 11 0.2× 10 0.2× 40 408
Giampaolo Bianchi Italy 9 73 0.9× 19 0.3× 39 0.6× 17 0.3× 9 0.2× 16 356
Pavel Geier Canada 9 61 0.7× 48 0.7× 12 0.2× 8 0.2× 8 0.2× 19 288
Jordi Calabia Martínez Spain 8 65 0.8× 13 0.2× 21 0.3× 7 0.1× 27 0.6× 20 316
Bahadır Ege Türkiye 12 21 0.2× 12 0.2× 25 0.4× 42 0.8× 19 0.4× 27 265

Countries citing papers authored by Karan Kanhai

Since Specialization
Citations

This map shows the geographic impact of Karan Kanhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karan Kanhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karan Kanhai more than expected).

Fields of papers citing papers by Karan Kanhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karan Kanhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karan Kanhai. The network helps show where Karan Kanhai may publish in the future.

Co-authorship network of co-authors of Karan Kanhai

This figure shows the co-authorship network connecting the top 25 collaborators of Karan Kanhai. A scholar is included among the top collaborators of Karan Kanhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karan Kanhai. Karan Kanhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hoffmann, Christian, et al.. (2024). The clinical picture of Castleman disease: a systematic review and meta-analysis. Blood Advances. 8(18). 4924–4935. 3 indexed citations
2.
Kanhai, Karan, et al.. (2023). The Clinical Picture of Castleman Disease: A Systemic Review and Meta-Analysis of Almost 2000 Patients. Blood. 142(Supplement 1). 1751–1751. 1 indexed citations
3.
Fajgenbaum, David C., Sheila K. Pierson, Karan Kanhai, et al.. (2022). The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry. British Journal of Haematology. 198(2). 307–316. 4 indexed citations
4.
Rhee, Frits van, Adam Rosenthal, Karan Kanhai, et al.. (2022). Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Advances. 6(16). 4773–4781. 17 indexed citations
5.
Rossi, Jean‐François, Zhaoyang Lu, Kalle Levón, et al.. (2022). Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling. Frontiers in Immunology. 13. 919489–919489. 9 indexed citations
6.
Mukherjee, Sudipto, Karan Kanhai, David Kauffman, et al.. (2022). Organ dysfunction, thrombotic events and malignancies in patients with idiopathic multicentric castleman disease: a population-level US health claims analysis. Leukemia. 36(10). 2539–2543. 7 indexed citations
7.
8.
Pierson, Sheila K., Karan Kanhai, Adam Bagg, et al.. (2021). Characterizing Mortality Associated with Idiopathic Multicentric Castleman Disease. Blood. 138(Supplement 1). 1623–1623. 2 indexed citations
9.
10.
Rhee, Frits van, Corey Casper, Peter M. Voorhees, et al.. (2020). Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. The Lancet Haematology. 7(3). e209–e217. 32 indexed citations
11.
Shim, Sung Ryul, Karan Kanhai, Young Myoung Ko, & Jae Heon Kim. (2016). Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression. The Journal of Urology. 197(2). 465–479. 79 indexed citations
12.
Tournoij, E., Ron J.G. Peters, Machteld Langenberg, Karan Kanhai, & Frans L. Moll. (2009). The Prevalence of Intolerance for Low-Dose Acetylsalicylacid in the Secondary Prevention of Atherothrombosis. European Journal of Vascular and Endovascular Surgery. 37(5). 597–603. 21 indexed citations
13.
Kanhai, Karan. (2001). Non-invasive respiratory monitoring in surgical intensive care. Data Archiving and Networked Services (DANS). 1 indexed citations
14.
Kanhai, Karan, et al.. (2000). Noninvasive monitoring of nonshunted pulmonary capillary blood flow in the acute respiratory distress syndrome. Critical Care Medicine. 28(4). 1059–1067. 1 indexed citations
15.
Avontuur, J.A., et al.. (1998). Effect of L-NAME, an Inhibitor of Nitric Oxide Synthesis, on Cardiopulmonary Function in Human Septic Shock. CHEST Journal. 113(6). 1640–1646. 25 indexed citations
16.
Avontuur, J.A., et al.. (1998). PULMONARY HYPERTENSION AND REDUCED CARDIAC OUTPUT DURING INHIBITION OF NITRIC OXIDE SYNTHESIS IN HUMAN SEPTIC SHOCK. Shock. 9(6). 451–454. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Yıldız Breakdown of academic impact, for papers by Jiyan Yuan Breakdown of academic impact, for papers by Takamasa Kobayashi Breakdown of academic impact, for papers by Jae Duck Choi Breakdown of academic impact, for papers by Mithat Büyükçelik Breakdown of academic impact, for papers by Kiyohide Sakai Breakdown of academic impact, for papers by Giampaolo Bianchi Breakdown of academic impact, for papers by Pavel Geier Breakdown of academic impact, for papers by Jordi Calabia Martínez Breakdown of academic impact, for papers by Bahadır Ege
Rankless by CCL
2026